For Indian pharmaceutical companies that already supply nearly half of all generic medicines sold in the US, the decision ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to ...

There was a time when Nvidia was a company responsible for making video games look better. Those carefree days are over, says ...

A $2.5 million grant from Lilly Endowment to the Indiana State Museum and Historic Sites will fund "a multi-year ...

In what may become a defining moment for the semiconductor industry, Samsung has announced the creation of an “AI Megafactory ...

In addition to purchase of Nvidia's chips, Samsung to also make use of chip giant's Omniverse platform to scale ...

U.S. stocks fell sharply with the S&P 500 and Dow ending lower after weak reactions to Meta and Microsoft earnings while traders largely ignored positive U.S.-China trade signals.

Recent health news highlights include Calley Means leaving his advisory role at the White House, Cipla CEO Umang Vohra ...

Argosy Investors reflects on Q3 moves, exiting Post Holdings and adding Endava and Novo Nordisk. Learn why overlooked sectors ...